CDC’s flip on asymptomatic COVID-19 testing in exposed individuals has drawn rebuke from at least two state governors, and further jeopardizes public confidence in the agency’s independence. According...

A Chinese Academy of Sciences team has provided evidence showing a mAb against SARS-CoV-2 from Lilly and Junshi is effective in monkeys -- a first for any COVID-19 mAb, according to the researchers -- and...

The University of Oxford, which aims to have its COVID-19 vaccine available for emergency use by September, revealed animal data Thursday supporting its clinical candidate’s safety and protectiveness. Oxford’s Jenner Institute is collaborating with Vaccitech...

China’s biotech sector may still be developing, but the COVID-19 crisis has revealed just how swiftly it can bring new vaccines to the clinic. The country has more COVID-19 vaccine candidates in human testing than...

As Moderna readies a Phase II trial of its COVID-19 vaccine just 12 weeks after the virus was sequenced, CEO Stéphane Bancel told BioCentury that the speed of the company mRNA platform could also be...

A COVID-19 vaccine from BioNTech and Pfizer could be available for emergency use by October -- several months ahead of a J&J vaccine and just off the pace of vaccines from Oxford’s Jenner Institute and...